Authors:
Thomas, X
Dombret, H
Cordonnier, C
Pigneux, A
Gardin, C
Guerci, A
Vekhoff, A
Sadoun, A
Stamatoullas, A
Fegueux, N
Maloisel, F
Cahn, JY
Reman, O
Gratecos, N
Berthou, C
Huguet, F
Kotoucek, P
Travade, P
Buzyn, A
de Revel, T
Vilque, JP
Naccache, P
Chomienne, C
Degos, L
Fenaux, P
Citation: X. Thomas et al., Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation, LEUKEMIA, 14(6), 2000, pp. 1006-1013
Authors:
Levy, V
Marjanovic, Z
Vekhoff, A
Belhocine, R
Marie, JP
Delmer, A
Ajchenbaum-Cymbalista, F
Zittoun, R
Rio, B
Citation: V. Levy et al., Relapse after autologous hematopoietic stem cell transplantation in acute myeloid leukemia, a single center experience over 13 years, AM J HEMAT, 64(3), 2000, pp. 232-233
Authors:
Thomas, X
Cambier, N
Taksin, AL
Reman, O
Vekhoff, A
Pautas, C
Leblond, V
Soler-Michel, P
Ecstein-Fraisse, E
Archimbaud, E
Citation: X. Thomas et al., Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia, LEUK RES, 24(11), 2000, pp. 957-963
Authors:
Marie, JP
Marjanovic, Z
Vekhoff, A
Bouvet, A
Chast, F
Levy, V
Baudard, M
Legrand, O
Rio, B
Delmer, A
Zittoun, R
Citation: Jp. Marie et al., Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycinas empiric therapy for fever in severely neutropenic patients, SUPP CARE C, 7(2), 1999, pp. 89-94
Authors:
Thomas, X
Fenaux, P
Dombret, H
Delair, S
Dreyfus, F
Tilly, H
Vekhoff, A
Cony-Makhoul, P
Leblond, V
Troussard, X
Cordonnier, C
de Revel, T
Simon, M
Nicolini, F
Stoppa, AM
Janvier, M
Bordessoule, D
Rousselot, P
Ffrench, M
Marie, JP
Archimbaud, E
Citation: X. Thomas et al., Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial), LEUKEMIA, 13(8), 1999, pp. 1214-1220